Detail akcie ICU Medical Inc online

Business Summary: ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume intravenous (IV) pumps and safety software, dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, sharps safety products, and sterile IV solutions. Its product offerings also include Consumables, Infusion Systems and Vital Care. Its consumables business unit includes infusion therapy, oncology, vascular access, and tracheostomy products. Its infusion systems offer a portfolio of infusion pumps, software, and professional services. Its vital care business unit includes hemodynamic monitoring, general anesthesia and respiratory, temperature management solutions and regional anesthesia/pain management products. Its infusion therapy products include infusion sets, extension sets, needle-free connectors, and disinfection caps.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, ICU Medical Inc revenues decreased 6% to $2.23B. Net income totaled $732K vs. loss of $117.7M. Revenues reflect Vital Care segment decrease of 37% to $437.9M, United States segment decrease of 11% to $1.36B. Net Income reflects Selling, general and administrative - decrease of 2% to $623.3M (expense), Foreign Exchange Gain/LossNon-Business increase from $9.8M (expense) to $3.8M (income).